DIAN P2 Endokrin

download DIAN P2 Endokrin

of 39

Transcript of DIAN P2 Endokrin

  • 8/20/2019 DIAN P2 Endokrin

    1/96

    ANATOMI

  • 8/20/2019 DIAN P2 Endokrin

    2/96

    GLANDULA TIROID

    Terdapat dibagian bawah leherikut bergerak ketika menelanBentuk seperti kupu-kupu, terdiri atas 2 lobusyang dihubungkan oleh isthmus yang

    menyilang digaris tengah setinggi cincincartilage tracea 2,3,4. Lebih kurang 40 akanterdapat lobus piramidalis, muncul dari bagianpermukaan atas isthmus, yang lebih sering daribagian kiri garis tengah.Bagian atas dari lobus piramidalis dapat berupa!bromuscular : Levator Glandula tiroid yangmenu"u ke os hyoid. #ada kasus dimana lobuspiramidalis tidak ada, pita !bromuscular initerdapat di bagian atas isthmus.

  • 8/20/2019 DIAN P2 Endokrin

    3/96

    • $landula thyroid merupakan organ yangsangat %ascular

    • &ibungkus oleh ' Fascia Pretrachealisyang melekatkan organ ini pada laryn( dantrachea

    • )ascia ini ikut membentuk dan membatasipembagian lobus-lobusnya.

    • *etiap lobus berbentuk buah ad%okatdengan puncaknya mengarah ke atassampai ke linea oblig cartilagenis trachea.Basisnya terdapat di bawah, setinggi cincintrachea ke 4 + .

  • 8/20/2019 DIAN P2 Endokrin

    4/96

  • 8/20/2019 DIAN P2 Endokrin

    5/96

    Alat-alat disekitarnya

    Anterolateral :o m. sternoth roido venter su!erior m.

    omoh ooideuso m. sternoh oideus

    o te!i anterior m.sternocleidomastoideus

  • 8/20/2019 DIAN P2 Endokrin

    6/96

    Alat-alat disekitarnya

    Posterolateral :

    o A.carotis commu

    niso ". #u$ularis internao N. va$us

  • 8/20/2019 DIAN P2 Endokrin

    7/96

    Alat-alat disekitarnya

    Medial :o Lar n%&tracheao m. constrictor

    !har n$is in'erioro Oeso!ha$uso antara oeso!ha$us

    dan tracheaterda!atN.Lar n$eusrecurrens Posterior :

    o Glandula!arath roidsu!erior dananterior

    o Anastomose antara

    A. th roideasu!erior dan

  • 8/20/2019 DIAN P2 Endokrin

    8/96

    #erdarahan

    . . Thyroidea superior• cabang . carotis e(terna

    2. . Thyroidea in/erior• cabang truncus thyrocer%icalis

    • ber"alan naik di belakang kelen"ar sampai setinggicartilage cricoidea, kemudian membelok kemedial bawah mencapai batas posterior kelen"ar.

    • . laryngicus recurrens melintasi bagian depanatau bagian belakang arteri ini.

    3. . Thyroidea 1ma• ika ada merupakan cabang . Brachiocephalicaatau arcus aorta

    • Ber"alan naik di depan trachea menu"u isthmus

    (erasaldari :

  • 8/20/2019 DIAN P2 Endokrin

    9/96

  • 8/20/2019 DIAN P2 Endokrin

    10/96

    Pem)uluh )ali*

    . . Thyroidea superior ' mencurahkanisinya ke %ena "ugularis interna

    2. . thyroidea media ' bermuara ke %ena

    "ugularis interna3. . Thyroidea in/erior ' menampung darahdari isthmus dan polus bawah kelen"ar,

    ena ini dari kedua sisi akan

    beranastomose sewaktu ber"alan turun kebawah di depan trachea dan bermuara ke. brachiocephalica

  • 8/20/2019 DIAN P2 Endokrin

    11/96

    Pem)uluhlim'eLim/e akan dialirkan ke lateral, ke nLl.

    er%icalis pro/unda. Beberapa pembuluhmenu"u nLl. #aratrachealis

    Pem)uluhsara' &isara! oleh serabut post ganglionik simpatisyang berasal dari ganglion cer%icalis superior,media, dan in/erior. *erabut-serabut ini

    mengikuti pinggir arteri, didistribusikanterutama pada pembuluh darah, hanya sedikitke sel /olikel. Beberapa serabut . %agus "ugamengikuti arteri ke kelen"ar ini.

  • 8/20/2019 DIAN P2 Endokrin

    12/96

    +,L,N-AR PARAT /ROID

    (entu* :o #ipih, o%al, ukuran 3 + 5 mm ( 2 + mm

    ( 0, + 2 mm. 6arna kuning kemerahan

  • 8/20/2019 DIAN P2 Endokrin

    13/96

  • 8/20/2019 DIAN P2 Endokrin

    14/96

    Leta* :o permukaan posterior lobus lateralis glandula thyroid,

    biasanya ber"umlah 4 buah.

    o 7elen"ar parathyroid superior ' terletak di belakang parssuperior glandula thyroid

    o 7elen"ar parathyroid in/erior ' terletak di dekat tempatmasuknya . Thyroidea in/erior, posisi dan "umlahnyaber%ariasi. 7elen"ar parathyroid dapat tertanam padakelen"ar thyroid

  • 8/20/2019 DIAN P2 Endokrin

    15/96

    Perdarahan :

    abang-cabang . Thyroidea terutamadari . Thyroidea in/erior, "uga darianastomose cabang yang mendarahi m.pre%ertebralis, pharyn( dan oesophagus.

    Persara'an :o Berasal dari sistim simpatis yang

    menyertai arteri, terbanyak berasal dariganglion 8

    o #ars in/erior berhubungan erat dengan .recurrens laryngeal

  • 8/20/2019 DIAN P2 Endokrin

    16/96

    FI0IOLOGI

  • 8/20/2019 DIAN P2 Endokrin

    17/96

    )isiologi 7elen"ar Tiroid

    +ontrol Terhada! +elen#ar Tiroid

    9ipotalamus

    T:9

    #ituitari anterior

    T*9

    Tiroid

    T3 T4

    1

    ;

    $ondok berkembang

    Tiroid

    Tdk memenuhipenyedianan tiroksin

    T*9

    9iperplasi <hipertro!

  • 8/20/2019 DIAN P2 Endokrin

    18/96

    • Fun$si Tiroid&=emacu metabolismeBerkaitan dengan suhu lingkungan- 7alorigenesis*tres T9 sumber 7alorigenesis =etabolisme Lemak < karbohidrat

    -9ipertiroidisme- suhu tubuh tinggi, banyak berkeringat, penurunan

    bobot tubuh, iritabilitas, dan tekanan darah tinggi

    - 9ipotiroidisme- bobot tubuh meningkat, lamban dan tidak adatoleransi terhadap udara dingin pada waktudewasa.

    -#erkembangan

  • 8/20/2019 DIAN P2 Endokrin

    19/96

    #aratiroid

    • Bentuk pipih, o%al > seperi buah pear, letakpermukaan posterior lobus lateralis tiroid

    • #aratiroid, kalsitonin dan dihidroksikolekalsi/erolmerupakan hormon utama berkaitan denganmetabolisme seperti '

    » 7alsium» #iro/os/at» =agnesium» #engaturan metabolisme tulang» &an komponen organik

  • 8/20/2019 DIAN P2 Endokrin

    20/96

    Meta)olisme +alsium

    • ?? ion a@@ berupa kristal mineral tulang• 7alsium memiliki 3 /ungsi dalam sel

    - 7omponen kunci dalam membran sel,permeabilitas serta si/at listriknya- *ebagai /aktor perangkai selama ekksitasi dankontraksi semua "enis otot.- *tadium awal untuk merangkai tanggapan selsasaran terhadap hormon.

    7alsium diserap diusus dibantu oleh ,2 -&ihidroksikolekalsi/erol metabolit it &3 digin"alyang dikontrol oleh paratiroid.

  • 8/20/2019 DIAN P2 Endokrin

    21/96

    Biosintesis #T9• #T9 sapi, manusia dan babi polipeptida linier

    dengan B= ? 00 dan 54 residu aa• #T9 disintesis sbg prapro-#T9 A residu aa• #rapro-#T9 masuk :C 2 residu aa

    dikeluarkan dr terminal #ro-#T9 A?0 residu aa

    • &i aparatus golgi 8 residu aa dari terminal dikeluarkan lagi #T9 A 54 residu aa• 7adar normal #T9 dlm plasma D 0- pg>ml• 6aktu paruh kurang dari 20 mnt

    • #olipeptida disekresikan akan diuraikan oleh sel-sel kuEer di hati m"d 2 polipeptida

    • )ragmen terminal yang tdk akti/ B= F000 dan/ragmen terminal yang akti/ dgn B= 2 00

  • 8/20/2019 DIAN P2 Endokrin

    22/96

    9ipoparatiroidisme

    • #engambilan tiroid kadar kalsium turun• 9ipokalsemia hilang kemampuan

    mobilisasi kalsium oleh tulang, gin"al dan usus

    • 1on kalsiun turun pada ekstrasel hiperiritabilitasneuromuskuler tetani, ke"ang otot,kematian

    • Transport kalsium usus turun ,2 -dihidroksikolekalsi/erol tidak terbentuk krn #T9tidak ada

  • 8/20/2019 DIAN P2 Endokrin

    23/96

    9iperparatiroidisme

    • =eningkatkan resropsi dan mobilisasikalsium, shg kalsium plasma meningkatdan /os/at plasma menurun

    • #T9 meningkatkan ekskresi /os/at dalamurin A reabsropsi /os/at ditubulusproksimal menurun dan reabsropsi ionkalsium meningkat ditubulus distal.

    • #eningkatan reabsropsi kalsium oleh usus• =enyebabkan kelumpuhan pada tulang

    karena tingginya deposisi kalsiumsehingga menghilangkan mineral

  • 8/20/2019 DIAN P2 Endokrin

    24/96

    7alsitonin

    :antai polipeptida td 32 residu aa ,B= 3000

    &ilepaskan "ika kalsium serum tinggi Beker"a di tulang dan gin"al

    #enghambat reabsropsi =encegah pelunakan tulang

  • 8/20/2019 DIAN P2 Endokrin

    25/96

    )ungsi ,2 -&ihidroksikolekalsi/erol

    • Bereaksi seirama dgn #T9, mengontrolmineralisasi tulang

    • =eningkatkan reabsropsi kalsium dan /os/at olehtubuli gin"al

    • =eningkatkan transport kalsium dan /os/at yangmelintasi sel-sel mukosa usus.

  • 8/20/2019 DIAN P2 Endokrin

    26/96

    (IO+IMIA

  • 8/20/2019 DIAN P2 Endokrin

    27/96

    Thyroid :egulation

    Somatostatin,Glucocorticoid

    Do!amine

  • 8/20/2019 DIAN P2 Endokrin

    28/96

    Thyroid hormone synthesis 1odide pump

    • :ate +limiting step in thyroid hormone synthesiswhich needs energy• )ollicles ha%e in their basement membrane an

    iodide trapping mechanism which pumps dietary 1 - into the cell

    • ormal thyroid' serum iodine is 30-40' – 1odide uptake enhancers'• T*9• 1odine de!ciency• T*9 receptors antibody

    – 1odide uptake inhibitors• 1odide ion• &rugs

    – &igo(in – Thiocynate – perchlorate

  • 8/20/2019 DIAN P2 Endokrin

    29/96

    Thyroid hormone synthesis

    2 1odide o(idation to iodine andGrgani!cation

    • 1nside the cells, iodide is o(idiHed by

    pero(idase system to more reacti%eiodine• 1odine immediately reacts with tyrosine

    residue on a thyroid glycoprotein calledIthyroglobulinJ to /orm '

    – T K mono-iodotyrosyl thyroglobulin – T2K di-iodotyrosyl thyroglobulin

    • Both processes are catalyHed by thyroidpero(idase enHyme

  • 8/20/2019 DIAN P2 Endokrin

    30/96

    Thyroid hormone synthesis

    3 oupling• T < T2 couple together to /orm T3

  • 8/20/2019 DIAN P2 Endokrin

    31/96

  • 8/20/2019 DIAN P2 Endokrin

    32/96

    CEects o/ thyroid hormones

    • )etal brain < skeletal maturation• 1ncrease in basal metabolic rate• 1notropic < chronotropic eEects on heart• 1ncreases sensiti%ity to catecholamines• *timulates gut motility• 1ncrease bone turno%er• 1ncrease in serum glucose, decrease in

    serum cholesterol• on%ersion o/ carotene to %itamin • #lay role in thermal regulation

  • 8/20/2019 DIAN P2 Endokrin

    33/96

    Increase BMR ( Basal Metabolic Rate )• ↑cellular metabolic activity by :

    • ↑ si e, total membrane sur!ace " number o! mitoc#ondria

    • ↑ $%& !ormation

    • ↑ active trans'ort o! ions ( a , * )

    &romote +ro t# " develo'ment o! t#e brain durin+!etal li!e and !or t#e !irst !e years o! 'ostnatal li!e

    -arbo#ydrate metabolism

  • 8/20/2019 DIAN P2 Endokrin

    34/96

    arbo#ydrate metabolism

    • en#anced +lycolysis, +luconeo+enesis,

    • GI absor'tion " insulin secretion

    .at metabolism

    • en#anced !at metabolism

    • $ccelerates t#e o/idation o! !ree !atty acids by t#e cells

    • 'lasma c#olesterol, '#os'#oli'ids " tri+lycerides

    Body ei+#t

    ↑ t#e a''etite, !ood inta0e, GI motility but 1 t#e body ei+#t

  • 8/20/2019 DIAN P2 Endokrin

    35/96

    • Cardiovascular system

    • vasodilatation

    • ↑ blood lo!

    • ↑ cardiac output

    • ↑ "eart rate

    • #espiratory

    ↑ t"e rate and dept" respiration

    • CNS

    e$treme nervous % psyc"oneurotic tendency

    • &uscle

    ma'e t"e muscles react !it" vi or -----muscle tremor ( * -*, times/sec )

    • Sleep e$treme ati ue but is di icult to sleep

  • 8/20/2019 DIAN P2 Endokrin

    36/96

    +,LAINAN TIROID

  • 8/20/2019 DIAN P2 Endokrin

    37/96

    auses , linical )eatures< onse uences o/

    9ypothyroidism

    ongenital 9ypothyroidism

    c uired 9ypothyroidism

  • 8/20/2019 DIAN P2 Endokrin

    38/96

    Ctiology

    • ongenital• c uired

    – #rimary – *econdary – Tertiary

  • 8/20/2019 DIAN P2 Endokrin

    39/96

    ongenital 9ypothyroidism• Gccurs in about >4000 li%e birth

    • Thyro(in is important /or * de%elopmentand postnatal growth

    • The most /re uent cause is congenitalabsence o/ the thyroid gland Aathyrosis

    • #resentations may include cyanosis,prolonged hyperbilirubinemia, poor /eeding,hoarse cry, umbilical hernia, respiratory

    distress, macroglossia, large /ontanelle, anddelayed skeletal maturation• :arely, neonatal hypothyroidism is transient

  • 8/20/2019 DIAN P2 Endokrin

    40/96

    ongenital 9ypothyroidismCtiology

    Thyroid dysgenesis 1diopathic'• ommonest cause in ? o/ cases

    – thyreosis A40

    – 9ypoplasia A40 – Cctopia Abase o/ tongue, midline A20

    2 Thyroid dyshormonogenesis A .: A 0

    3 9ypothalamic-pituitary hypothyroidism – nencephaly, holoprosencephaly, *.G.& – idiopathic

  • 8/20/2019 DIAN P2 Endokrin

    41/96

    ongenital

  • 8/20/2019 DIAN P2 Endokrin

    42/96

    ongenital9ypothyroidism

    4 Transient hypothyroidism – =aternal T: B – =aternal ingestion o/ goitrogen &rugs

    8 1odine e(cessF 1odine de!ciency

    i h id & d

  • 8/20/2019 DIAN P2 Endokrin

    43/96

    nti-thyroid &rugs and/etus

    • Thionamides – #TM < =NT

    • 1odide• Lithium• miodarone• :adioiodine

    – /ter 0- 2 wk gestation candamage

    /etal thyroid gland

    #resentations o/ congenital

  • 8/20/2019 DIAN P2 Endokrin

    44/96

    #resentations o/ congenitalhypothyroidism

    • =acroglosia• #rolonged hyperbilirubinemia• #oor /eeding• 9oarse cry• &ecreased acti%ity• onstipation• Mmbilical hernia

    • &ry yellow skin• large /ontanelle• &elayed skeletal maturation

    t l i g / g it l

  • 8/20/2019 DIAN P2 Endokrin

    45/96

    eonatal screening /or congenitalhypothyroidism

    • :outine in most countries worldwide

    • )ilter paper blood spot measuring T*9• 6hy OO

    • linical mani/estations at birth, usually are subtle ore%en absent Apassi%e transplacental maternalthyro(in

    • t birth, surge o/ T*9 Astress o/ deli%ery up to 30 -40Pu>ml

    • Carly detection will pre%ent mental retardation ordecreasing 1Q o/ aEected neonates

    • Thyro(in is important /or * de%elopment /rom birthtill 3 years o/ li/e

    • *creening program will miss 2ry> tertiary cases• The program is hampered by a high rate o/ /alse

    positi%e results

  • 8/20/2019 DIAN P2 Endokrin

    46/96

    c uired 9ypothyroidism

    • =ore common than hyperthyroidism• ?? is primary AR due to T*9 de!ciency• 9ashimoto ’ s

    – most common thyroid problem A4 o/

    population – most common cause in iodine-replete

    areas – chronic lymphocytic thyroiditis – ssociated with T#G antibodies A?0 , less

    commonly Tg antibodies• 1atrogenic 9ypothyroidism /rom radioacti%e

    iodine therapy

  • 8/20/2019 DIAN P2 Endokrin

    47/96

    c uired 9ypothyroidism

    • *ubacute thyroiditis – #ain/ul, o/ten radiates to the ear – c>o malaise, pharyngitis, /atigue, /e%er, neck pain>swelling – iral etiology AM:1> pharyngitis – sel/-limited. an t( inSammation w> * , * 1& s or

    steroids

    • *uppurati%e> cute 1n/ectious thyroiditis – 1n/ections o/ the thyroid are rare

    • normally protected /rom in/ection by its thick capsule

    – Bacterial UU /ungal, mycobacterial or parasitic – #t s are acutely ill w> a pain/ul thyroid gland

    • assoc w> /e%er>chills, anterior neck pain>swelling,dysphagia and dysphonia

  • 8/20/2019 DIAN P2 Endokrin

    48/96

    c uired 9ypothyroidism

    • *ymptoms – $eneral *lowing &own – Lethargy>somnolence – &epression – =odest 6eight $ain – old 1ntolerance – 9oarseness – &ry skin – onstipation A 2 peristaltic acti%ity – $eneral ches>#ains

    • rthralgias or myalgias

    Aworsened by cold temps – Brittle 9air – =enstrual irregularities

    • C(cessi%e bleeding• )ailure o/ o%ulation

    – 2 Libido

    i d 9 h idi

  • 8/20/2019 DIAN P2 Endokrin

    49/96

    c uired 9ypothyroidism

    C(amination• &ry, pale, course skin with yellowish tinge• #eriorbital edema• #uEy /ace and e(tremities• *inus Bradycardia•

    &iastolic 9T• 2 Body temperature• &elayed rela(ation o/ reSe(es• =egacolon A 2 peristaltic acti%ity• #ericardial> pleural eEusions• ongesti%e heart /ailure• on-pitting edema• 9oarse %oice• =yopathy

  • 8/20/2019 DIAN P2 Endokrin

    50/96

    $oiter

    • swollen thyroid

    gland• ssessmentD

    – how big, howuickly has it

    de%eloped, is itsmooth or nodular,is it pain/ul, anyassociated lymphnodes, any sudden

    changes, is it bigenough to causelocal symptoms Ae.g.breathing

    problems

  • 8/20/2019 DIAN P2 Endokrin

    51/96

    Myxedema

    Hypothyroidism --- loss of scalp hair

  • 8/20/2019 DIAN P2 Endokrin

    52/96

    Hypothyroidism --- loss of scalp hair

    $ -olor $tlas o! 2ndocrinolo+y '34

    9 h idi i h h

  • 8/20/2019 DIAN P2 Endokrin

    53/96

    9ypothyroidism with shortstature

    &i i

  • 8/20/2019 DIAN P2 Endokrin

    54/96

    &iagnosis ongenital hypothyroidism

    • Thyroid hormone le%el• T*9• Thyroid scan

    c uired 9ypothyroidism

    • T*9• /T4• Thyroid antibodies• Thyroid ultrasound• T0 ' low in secondary hypothyroidism

    high in primary hypothyroidism• TR test: to diEerentiate between

    secondary < Tertiary hypothyroidism

  • 8/20/2019 DIAN P2 Endokrin

    55/96

  • 8/20/2019 DIAN P2 Endokrin

    56/96

  • 8/20/2019 DIAN P2 Endokrin

    57/96

  • 8/20/2019 DIAN P2 Endokrin

    58/96

    auses , linical )eatures< onse uences o/

    9yperthyroidism

  • 8/20/2019 DIAN P2 Endokrin

    59/96

    9yperthyroidism AThyroto(icosis

    &e!nition• C(cessi%e secretion o/ T3 < T4• Eects metabolic processes in all

    body organs• 9yperthyroidism is 4- 0 times more

    pre%alent in women

    • =ost common endocrine diseasesecond only to diabetes as the mostoccurring endocrine disease

  • 8/20/2019 DIAN P2 Endokrin

    60/96

    Thyroto(icosisauses

    Transient . eonatal thyroto(icosis

    2.1n/ectious ' cute < subacute thyroiditis3.&rug + induced' miodarone, inter/eron

  • 8/20/2019 DIAN P2 Endokrin

    61/96

    Thyroto(icosis

    auses

    #ersistent.$ra%es disease

    2.To(ic multinodular goiter3.To(ic solitary adenoma

    4. entral Apituitary origin

    eonatal Thyroto(icosis

  • 8/20/2019 DIAN P2 Endokrin

    62/96

    eonatal Thyroto(icosis• Gnly occur with o/ thyroto(ic mothers

    • *e%erity consistent in /uture pregnancies• 20 mortality i/ untreated• C%ol%es rapidly, e%ident by day F o/ li/e,

    unless T: B blocking antibody is present

    • ssociate with cranial synostosis andlearning diVculties, i/ not treated

    • )etal thyroto(icosis in rats leads toabnormal * myelination

    • #arents should be aware o/ potentiallearning problems Aearly school yearsshould be monitored

    eonatal #y'ert#yroidism born to mot#er

  • 8/20/2019 DIAN P2 Endokrin

    63/96

    eonatal #y ert#yroidism born to mot#erit# Graves5 disease

    $ -olor $tlas o! 2ndocrinolo+y '67

    $ra%e s disease

  • 8/20/2019 DIAN P2 Endokrin

    64/96

    $ra%e s disease#athogenesis• T-cell dependent autoimmune disease• 80 ha%e 9L association with ,

    B5, &:3,&:4,&:

    • utoimmune disorder that results inproduction o/ antibodies directedagainst thyroid antigens' – T*9 receptors – Thyroglobulin – Thyroid pero(idase

    * b t Th iditi

  • 8/20/2019 DIAN P2 Endokrin

    65/96

    *ubacute Thyroiditis• linical course lasts weeks to months• cute phase A2-8> 2 with clinical and

    biochemical hyperthyroidism• :eco%ery phase Aweeks-months transient

    hypothyroidism then euthyroidism• linically, history o/ sore throat, /e%er,

    tender goiter, cer%ical lymphadenopathy• 9igh C*:, negati%e antibodies and absent

    radioacti%e 1 3 uptake

    9yperthyroidism

  • 8/20/2019 DIAN P2 Endokrin

    66/96

    9yperthyroidism

    • =ay result in signi!cant

    morbidity, mortality < e%en death• *ymptoms – ittery, shaky, ner%ous – &iVculty concentrating

    – Cmotional lability – 1nsomnia – :apid 9:, palpitations, )eeling

    9ot

    – 6eight Loss – &iarrhea – )atigue – =enses ' lighter Sow, shorter

    duration

  • 8/20/2019 DIAN P2 Endokrin

    67/96

    9yperthyroidism

    • C(am – Cye !ndings A20 – $oiter – Thyroid bruit or thrill – Tachycardia' *inus Tachycardia,

    trial )ibrillation – )low murmur – *ystolic hypertension – 9yperreSe(ia – Tremors

    – #ro(imal muscle weakness – lubbing – Gnycholysis AR

    • separation o/ nail /rom thenailbed

    – &ermopathy A

    Th t (i i

  • 8/20/2019 DIAN P2 Endokrin

    68/96

    Thyroto(icosis

    • 9eart' 1ncreased heart rate, contractilityand cardiac output• *keletal muscles' #ro(imal myopathy, easy

    /atigability and muscle atrophy

    • $onads' 1rregular menstrual cycles,impotence• Li%er' Low cholesterol L&L <

    apolipoprotein

    • Bone' 1ncreased bone turno%er,osteoporosis < increased risk o/ /racture

    $ % W h h l h

  • 8/20/2019 DIAN P2 Endokrin

    69/96

    $ra%eWs ophthalmopathy• The pathogenesis o/ in!ltrati%e

    ophthalmopathy is poorly understood• 1t may occur be/ore the onset o/hyperthyroidism or as late as to 20 years

    • The clinical course o/ ophthalmopathy isindependent o/ the clinical course o/hyperthyroidism

    • 1n!ltrati%e ophthalmopathy may result /romimmunoglobulins directed to speci!cantigens in the e(traocular muscles <

    orbital !broblasts• The antibodies are distinct /rom thoseinitiating $ra%esW-type hyperthyroidism

  • 8/20/2019 DIAN P2 Endokrin

    70/96

    9 th id C &i

  • 8/20/2019 DIAN P2 Endokrin

    71/96

    9yperthyroid Cye &isease

    • 9yperthyroidism Aany cause

    – Lid lag, lid retraction and stare – &ue to increased adrenergic

    tone stimulating the le%atorpalpebral muscles.

    • True $ra%es’

    Gphthalmopathy – #roptosis – &iplopia – 1nSammatory changes

    • on"uncti%al in"ection

    • #eriorbital edema• hemosis – &ue to thyroid auto b s that

    cross-react w> g s in!broblasts, adipo-cytes, @myocytes behind the eyes.

    Grave5s o'#t#almo'at#y

  • 8/20/2019 DIAN P2 Endokrin

    72/96

    y

    9 th id C &i

  • 8/20/2019 DIAN P2 Endokrin

    73/96

    9yperthyroid Cye &isease

    $ra%es &ermopathy

  • 8/20/2019 DIAN P2 Endokrin

    74/96

    $ra%es &ermopathy

    Thyroid &ermopathy – Thickening and redness

    o/ the dermis• &ue to lymphocytic

    in!ltration

    h d h

    http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom?picture=%5Cwebsites%5Cemedicine%5Cderm%5Cimages%5CLarge%5C346figure1.jpg&template=izoom2

  • 8/20/2019 DIAN P2 Endokrin

    75/96

    Thyroid cropachy

    Th roid acro!ach . This is most mar*ed in the inde% 3n$ers andthum)s

  • 8/20/2019 DIAN P2 Endokrin

    76/96

    %remor o! t#e #and

    $ -olor $tlas o! 2ndocrinolo+y '89

  • 8/20/2019 DIAN P2 Endokrin

    77/96

    &i i

  • 8/20/2019 DIAN P2 Endokrin

    78/96

    &iagnosis• T*9 le%el usually R 0.0 µ u > ml• ? o/ cases, high )T4 < )T3• 1n high )T3 with normal T4 AT3

    Thyroto(icosis• Thyroid receptor AT: B are usuallyele%ated at diagnosis

    • ntibodies against thyroglobulin,pero(idase or both are present inthe ma"ority o/ patients

  • 8/20/2019 DIAN P2 Endokrin

    79/96

    Thyroto(icosis- Treatment

  • 8/20/2019 DIAN P2 Endokrin

    80/96

    Thyroto(icosis Treatment

    • Three modalities /or more than last 0 years• :adioacti%e iodine,antithyroid drugs

  • 8/20/2019 DIAN P2 Endokrin

    81/96

    eonatal Thyroto(icosis Treatment

    Lugol s iodine• drop tid /or -2 > F• &ramatic coarse therapy• Blocks T4 release, synthesis and 1 uptake

    A6ol/ haikoE eEect2 #ropranolol3 arbimaHole

    will take se%eral days to ha%e an eEecton T4 synthesis

  • 8/20/2019 DIAN P2 Endokrin

    82/96

    9 th idi AT t t

  • 8/20/2019 DIAN P2 Endokrin

    83/96

    9yperthyroidism ATreatment

    3 ntithyroid &rugs A30 thyroidologists pre/er – #ropylthiouracil A#TM• 00 mg bid-tid to start

    – =ethimaHole• 0Z more potent the #TM

    • 0 mg bid-tid to start – omplications o/ T& s

    • granulocytosis A >200- 00 – usually presents w> acute pharyngitis> tonsilitis or

    pneumonia.

    • :ash• 9epatic necrosis, holestatic "aundice• rthralgia

    9 th idi AT t t

  • 8/20/2019 DIAN P2 Endokrin

    84/96

    9yperthyroidism ATreatment

    4 *urgeryAsub-total thyroidectomy

    – 1ndications• #atient pre/erence• Large or symptomatic goiters• 6hen there is uestion o/ malignancy

    – eed to be euthyroid prior to surgery• To [ the risk o/ arrhythmias during induction o/

    anesthesia• To [ the risk o/ thyroid storm post operati%ely• T& s @ X-blockers

    – :isks• #ermanent hypoparathyroidism• :ecurrent laryngeal ner%e problems• #ermanent hypothyroidism

  • 8/20/2019 DIAN P2 Endokrin

    85/96

    $ 71

    K&1)M* G TGZ1 $G1TC:KC &C=1 $G1TC:

  • 8/20/2019 DIAN P2 Endokrin

    86/96

    GA+I

    merupakan suatu masalah giHi yangdisebabkan karena kekuranganiodium .

    Ge#ala\ :eterdasi mental

    \ $angguan pendengaran\ $angguan bicara\ +retinisme )iasan a !ada ana*&

    ana*

  • 8/20/2019 DIAN P2 Endokrin

    87/96

    +lasi3*asi. $rade 0 ' ormal

    &engan inspeksi tidak terlihat , baik datar maupun tengadahmaksimal, dan dengan palpasi tidak teraba.

    2. $rade 17elen"ar $ondok tidak terlihat, baik datar maupun penderitatengadah maksimal, dan palpasi teraba lebih besar dariruas terakhir ibu "ari penderita.

    3. $rade 1B7elen"ar $ondok dengan inspeksi datar tidak terlihat, tetapiterlihat dengan tengadah maksimal dan dengan palpasiteraba lebih besar dari $rade 1 .

    4. $rade 117elen"ar $ondok dengan inspeksi terlihat dalam posisi datardan dengan palpasi teraba lebih besar dari $rade 1B .

    . $rade 1117elen"ar $ondok cukup besar, dapat terlihat pada "arak 8meter atau lebih.

    $angguan kibat $ 7^

  • 8/20/2019 DIAN P2 Endokrin

    88/96

    $angguan kibat $ 7^

    . Pada Fetus- bortus- *teel Birth- 7elainan 7ematian

    #erinatal- 7retin euroligi- 7retin

    =y(edematosa

    - &e/ek #sikomotor2. Pada Neonatal- 9ipotiroid- $ondok eonatal

    3. Pada Ana* danRema#a- -uvenile

    i!oth roidesm- $ondok Gan$$uan

    Fun$si Mental- Gan$$uan

    Per*em)an$an Fisi* - 7retin

    =y(edematosa daneurologi4. Pada De6asa- $ondok dan segala

    7omplikasinya-

  • 8/20/2019 DIAN P2 Endokrin

    89/96

    Dosis Pem)erian +a!sul /odium. nak *& Adaerah endemik berat '

    7 *a!sul8tahun

    2. &aerah endemik sedang dan berat '- 6anita Msia *ubur ' 2 7apsul>tahun_ 200 mg

    - 1bu hamil ' 7apsul>tahun

    - 1bu =enuyusui ' 7apsulselama menyusui

  • 8/20/2019 DIAN P2 Endokrin

    90/96

    7ecukupan iodium yang dian"urkanuntuk orang 1ndonesia antara lain '

    . Bayi A 2 bulan pertama 0mikrogram>hari

    2. nak Ausia 2-8 tahun ?0

    mikrogram>hari3. nak usia sekolah Ausia F- 2 tahun20

    mikrogram>hari4. &ewasa Adiatas usia 2 tahun 0

    mikrogram>hari. 1bu hamil F mikrogram>hari

    8 1bu menyusui 200 mikrogram>hari

    T1:G1&1T1*

  • 8/20/2019 DIAN P2 Endokrin

    91/96

    • 7MT A *M#M: T1)

    &isebut "uga in/ecti%e thyroiditis, in/eksioleh bakteri > "amur. ontoh kuman ' pneumococcus,streptococcus hemolyticus, dll.

    $e"ala 7linis ' nyeri dileher mendadak,malaise, demam, menggigil dan takikardi. #emeriksaan Lab ' leukositosis, LC&meningkat, sidikan tiroid menun"ukkan

    nodul dingin. #engobatan ' utama 'antibiotikkokus gram @ ' penisilin, tetrasiklin.

    "ika ada abses ' lobektomi.

    • *MB 7MT

  • 8/20/2019 DIAN P2 Endokrin

    92/96

    MB 7MT Mmumnya diduga karena %irus

    =7 ' pasien mengeluh dileher bagiandepan men"alar ke telinga, demam,malaise. #em.!sik ' tiroid membesar, nyeritekan,takikardi berkeringat, tremor, dll #em. Lab ' leukositosis, LC& meningkat,pada 2>3 kasus hormon tiroid meninggi. #engobatan ' biasanya sembuh sendirisehingga pengobatan yang diberikansimptomatis.- asetosal untk mengurangi nyeri- pada keadaan berat ' glukokortikoid

    • =C 9M

  • 8/20/2019 DIAN P2 Endokrin

    93/96

    • =C 9M7.LIMFO0ITI+ 9 A0 IMOTO

    *uatu tiroiditis autoimun dgn nama lain strumalim/omatosa=enyerang wanita berumur 30- 0 th7elen"ar tiroid biasanya membesar lambat, tdkterlalu besar, simetris, reguler, < padat. 7adang-kadang ada nyeri spontan < nyeri tekan. Bisaeutiroid>hipotiroid dan "arang hipertiroid.9istopatologi ' in!ltrasi lim/osit yg di/us, obliterasi/olikel tiroid dan !brosis.&iagnosis ' hanya dapat ditegakkan secara histologimelalui biopsi.#engobatan ' bila kelen"ar tiroid sangat besar pengangkatan.

    2. on spesi!k

    *T:M= G TG7*17

  • 8/20/2019 DIAN P2 Endokrin

    94/96

    *1=#LC7*• CT1GLG$1 & # TG$C C*1*

    a. *intesis hormon tiroid yg tganggu , misal krnde/.yodium, masukan goitrogen dr mknan ataude/ek pd "alur biosintetik hormon.b. ^odinisasi yg tidak sempurna dr tiroglobulin

    c. ntibodi yg menstimulasi pertumbuhan tiroid

    • # TGLG$1- pd stadium awal, kelen"ar mmperlihatkan

    hipertropi seragam, hiperplasia, danhiper%askularisasi- sebagian kelen"ar mmperlihatkan in%olusi atauhiperin%olusi yg seragam dg akumulasi koloid

    • = 1)C*T *1 7L1 1*

  • 8/20/2019 DIAN P2 Endokrin

    95/96

    = 1)C T 1 7L1 1- pembesaran tiroid

    - muka sembab, pusing, dan sinkopAtanda #emberton- suara parau

    • &1 $ G*1*- T4 dan T 3 serum mendekati batasnormal- : 1 normal namun mungkin dptmeningkat pd de/.yodium atau de/ekbiiosintesis

  • 8/20/2019 DIAN P2 Endokrin

    96/96

    • T T L 7*

    - untuk mengurangi ukuran strumabs dg menyediakan hormon eksogendlm "umlah cukup untukmenghambat sekresi T*9- pemberian hormon tiroid' Le%otiroksin dg dose' 00 `g stphari dan dosis ditingkatkan bulanberikutnya sampai maksimal 0atau 200 `g>hari.